Rowlett J K, Winger G, Carter R B, Wood P L, Woods J H, Woolverton W L
Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson 39216, USA.
Psychopharmacology (Berl). 1999 Jul;145(2):205-12. doi: 10.1007/s002130051050.
The present study was designed to assess possible abuse-related effects of the endogenous neuroactive steroid pregnanolone (3alpha-hydroxy-5beta-pregnan-20-one) and the orally bioavailable, water-soluble neuroactive steroid pro-drug Co 8-7071 (3alpha,21-dihydroxy-3beta-trifluoromethyl-5beta-pregnan-20- one, 21-hemisuccinate).
Four rhesus monkeys were prepared with chronic intravenous (i.v.) catheters and trained to press a lever under a ten-response fixed-ratio (FR) schedule of methohexital injection (0.1 mg/kg per injection). Three rhesus monkeys were trained to discriminate intragastric infusions of pentobarbital (10 mg/kg) from saline infusions under a FR5 schedule of stimulus-shock termination.
At least two doses of pregnanolone (0.003-0.1 mg/kg per injection) maintained injections per session above saline levels in the four monkeys tested, whereas Co 8-7071 (0.01-1.0 mg/kg per injection) maintained injections per session above saline levels in two of four monkeys at relatively low levels of injections per session. In rhesus monkeys trained to discriminate pentobarbital, i.v. pregnanolone injections (0.1-1.7 mg/kg, 5-min presession) dose-dependently reproduced the discriminative stimulus effects of pentobarbital in all monkeys tested. Intravenous administration of Co 8-7071 (1-10 mg/kg, 5-min presession) resulted in a dose-dependent increase to >80% pentobarbital-appropriate responding in two of three monkeys tested. Following intragastric infusions of Co 8-7071 (1.0-30 mg/kg), > or =80% pentobarbital-appropriate responding occurred in one out of three monkeys at 10 mg/kg when administered 60 min before the session. When administered 120 min before the session, however, 10-30 mg/kg Co 8-7071 reproduced the discriminative stimulus effects of pentobarbital in each of the three monkeys tested.
These data demonstrate barbiturate-like abuse-related effects that differed between two pregnane steroids. Whereas pregnanolone functioned as a reinforcer, suggesting that this compound has abuse potential, Co 8-7071 did not, despite having pentobarbital-like discriminative effects.
本研究旨在评估内源性神经活性甾体孕烷醇酮(3α-羟基-5β-孕烷-20-酮)以及口服生物可利用的水溶性神经活性甾体前药Co 8-7071(3α,21-二羟基-3β-三氟甲基-5β-孕烷-20-酮,21-半琥珀酸酯)可能与滥用相关的效应。
对4只恒河猴植入慢性静脉导管,并训练它们在甲己炔巴比妥注射(每次注射0.1 mg/kg)的10次反应固定比率(FR)程序下按压杠杆。对3只恒河猴进行训练,使其在刺激-电击终止的FR5程序下区分胃内输注的戊巴比妥(10 mg/kg)和生理盐水输注。
在接受测试的4只猴子中,至少两剂孕烷醇酮(每次注射0.003 - 0.1 mg/kg)使每次实验的注射次数维持在高于生理盐水水平,而Co 8-7071(每次注射0.01 - 1.0 mg/kg)在4只猴子中的2只中使每次实验的注射次数维持在高于生理盐水水平,但每次实验的注射次数相对较低。在经过训练以区分戊巴比妥的恒河猴中,静脉注射孕烷醇酮(0.1 - 1.7 mg/kg,实验前5分钟)在所有接受测试的猴子中均剂量依赖性地重现了戊巴比妥的辨别刺激效应。静脉注射Co 8-7071(1 - 10 mg/kg,实验前5分钟)导致在接受测试的3只猴子中的2只中,对戊巴比妥适当反应的剂量依赖性增加至>80%。在胃内输注Co 8-7071(1.0 - 30 mg/kg)后,在实验前60分钟给予10 mg/kg时,3只猴子中有1只出现了≥80%的戊巴比妥适当反应。然而,在实验前120分钟给予时,10 - 30 mg/kg的Co 8-7071在接受测试的3只猴子中的每只中都重现了戊巴比妥的辨别刺激效应。
这些数据表明两种孕烷类甾体之间存在与巴比妥类药物类似的与滥用相关的效应差异。孕烷醇酮起到强化剂的作用,表明该化合物具有滥用潜力,而Co 8-7071尽管具有类似戊巴比妥的辨别效应,但却没有这种作用。